tiprankstipranks
Autolus Therapeutics Plc (DE:6A3A)
FRANKFURT:6A3A
Germany Market

Autolus Therapeutics (6A3A) Technical Analysis

3 Followers

Summary of all the Indicators

Overall Consensus
Neutral
11Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Autolus Therapeutics Plc’s (6A3A) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Autolus Therapeutics Plc is a Buy.
Autolus Therapeutics Plc’s (6A3A) 20-Day exponential moving average is 1.88, while Autolus Therapeutics Plc’s (6A3A) share price is €2.06, making it a Sell.
Autolus Therapeutics Plc’s (6A3A) 50-Day exponential moving average is 1.73, while Autolus Therapeutics Plc’s (6A3A) share price is €2.06, making it a Buy.

Autolus Therapeutics (6A3A) Pivot Points

Sep 13, 2026, 08:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.80
1.80
1.80
1.80
1.80
1.80
1.80
Fibonacci
1.80
1.80
1.80
1.80
1.80
1.80
1.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Autolus Therapeutics (6A3A) Moving Averages

Sep 13, 2026, 08:47 PM
Period
Simple
Exponential
MA5
1.85Sell
1.83Sell
MA10
1.92Sell
1.88Sell
MA20
1.96Sell
1.88Sell
MA50
1.65Buy
1.73Buy
MA100
1.51Buy
1.58Buy
MA200
1.41Buy
1.46Buy
Autolus Therapeutics Plc’s (6A3A) 10-Day exponential moving average is 1.88, while Autolus Therapeutics Plc’s (6A3A) share price is €2.06, making it a Sell.
Autolus Therapeutics Plc’s (6A3A) 100-Day exponential moving average is 1.58, while Autolus Therapeutics Plc’s (6A3A) share price is €2.06, making it a Buy.
Autolus Therapeutics Plc’s (6A3A) stock price is €2.06 and Autolus Therapeutics Plc’s (6A3A) 50-day simple moving average is 1.65, creating a Buy signal.
Autolus Therapeutics Plc’s (6A3A) stock price is €2.06 and Autolus Therapeutics Plc’s (6A3A) 100-day simple moving average is 1.51, creating a Buy signal.
Autolus Therapeutics Plc’s (6A3A) stock price is €2.06 and Autolus Therapeutics Plc’s (6A3A) 200-day simple moving average is 1.41, creating a Buy signal.

Autolus Therapeutics (6A3A) Technical Indicators

Sep 13, 2026, 08:47 PM
Name
Value
Implied Action
RSI (14)
42.49
Neutral
STOCH (9,6)
>-0.01
Buy
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
0.04
Buy
ADX (14)
21.06
Neutral
Williams %R
-100.00
Buy
CCI (14)
-191.15
Buy
ATR (14)
0.06
-
Ultimate Oscillator
21.59
Sell
ROC
-16.83
Sell
Autolus Therapeutics Plc’s (6A3A) Relative Strength Index (RSI) is 42.49, creating a Neutral signal.
Autolus Therapeutics Plc’s (6A3A) Trend Strength Indicator (ADX) is 21.06, creating a Neutral signal.
Autolus Therapeutics Plc’s (6A3A) Commodity Channel Index (CCI) is -191.15, creating a Buy signal.
Autolus Therapeutics Plc’s (6A3A) Price Rate of Change (ROC) is -16.83, creating a Sell signal.

FAQ

Is 6A3A a Buy, Hold, or Sell?
Based on 6A3A’s technical indicators, 6A3A is a Hold.
    What is 6A3A’s RSI (14)?
    6A3A’s RSI (14) is 42.49, which suggests 6A3A is a Neutral.
      What is 6A3A’s MACD?
      6A3A’s MACD is 0.04, which suggests 6A3A is a Buy.
        What is 6A3A’s 5-day moving average?
        6A3A’s 5-day moving average is 1.85, which suggests 6A3A is a Sell.
          What is 6A3A’s 20-day moving average?
          6A3A 20-day moving average is 1.96, which suggests 6A3A is a Sell.
            What is 6A3A’s 50-day moving average?
            6A3A’s 50-day moving average is 1.65, which suggests 6A3A is a Buy.
              What is 6A3A’s 200-day moving average?
              6A3A’s 200-day moving average is 1.41, which suggests 6A3A is a Buy.
                What is 6A3A’s Williams % R (14)?
                6A3A’s Williams % R (14) is -100.00, which suggests 6A3A is a Buy.
                  What is 6A3A’s CCI (14)?
                  6A3A’s CCI (14) is -191.15, which suggests 6A3A is a Buy.
                    What is the share price of Autolus Therapeutics Plc?